Showing results (11-20 of 124) with videos related to

Sort By:
Pageof 13
The International Journal of Neuropsychopharmacology|June 23, 2017
Effect of Psilocybin on Empathy and Moral Decision-MakingThomas Pokorny, Katrin H Preller, Michael Kometer, et al.
Scientific Reports|October 26, 2019
Characterization and prediction of acute and sustained response to psychedelic psilocybin in a mindfulness group retreatLukasz Smigielski, Michael Kometer, Milan Scheidegger, et al.
Cerebral Cortex (New York, N.Y. : 1991)|July 18, 2013
Spatiotemporal brain dynamics of emotional face processing modulations induced by the serotonin 1A/2A receptor agonist psilocybinFosco Bernasconi, André Schmidt, Thomas Pokorny, et al.
Biological Psychiatry|December 4, 2010
The 5-HT2A/1A agonist psilocybin disrupts modal object completion associated with visual hallucinationsMichael Kometer, B Rael Cahn, David Andel, et al.
Cerebral Cortex (New York, N.Y. : 1991)|August 10, 2012
Modeling ketamine effects on synaptic plasticity during the mismatch negativityAndré Schmidt, Andreea O Diaconescu, Michael Kometer, et al.
Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology|October 28, 2011
Mismatch negativity encoding of prediction errors predicts S-ketamine-induced cognitive impairmentsAndré Schmidt, Rosilla Bachmann, Michael Kometer, et al.
Neurophotonics|December 7, 2022
Psychedelics and fNIRS neuroimaging: exploring new opportunitiesFelix Scholkmann, Franz X Vollenweider
Scientific Reports|March 27, 2024
Psilocybin enhances insightfulness in meditation: a perspective on the global topology of brain imaging during meditationBerit Singer, Daniel Meling, Matthias Hirsch-Hoffmann, et al.
Pageof 13